PLK-1
Aliases: | PLK, STPK13 |
---|---|
Other: | serine/threonine-protein kinase PLK1|PLK-1|cell cycle regulated protein kinase|polo (Drosophia)-like kinase|serine/threonine-protein kinase 13 |
The Ser/Thr protein kinase encoded by this gene belongs to the CDC5/Polo subfamily. It is highly expressed during mitosis and elevated levels are found in many different types of cancer. Depletion of this protein in cancer cells dramatically inhibited cell proliferation and induced apoptosis; hence, it is a target for cancer therapy. [provided by RefSeq, Sep 2015]
DyLight 550
Common Laser: | 561 |
---|---|
Common Filter: | 585/42 |
Excitation Peak: | 562 |
Emission Peak: | 576 |
DyLight™ 550 has an excitation peak at 562 nm and an emission peak at 576 nm and is spectrally similar to Alexa Fluor™ 546, Alexa Fluor™ 555, Cy3 and TRITC. DyLight™ 550 is most commonly used in flow cytometery and fluorescence microscopy applications.
Popular PLK-1 DyLight 550 Antibodies
Company / SKU |
Applications | Marker / Reactivity |
Host / Isotype / Clone |
Size / Price |
Details | |
---|---|---|---|---|---|---|
NB100-78464R |
WB,ICC/IF | PLK-1 Human,Mouse |
Mouse IgG1 κ 3F8 |
100 μl $369 |
Details | |
Novus Biologicals, a Bio-Techne brand NB100-547R |
WB,ICC,IF,IP | PLK-1 Human |
Rabbit IgG |
100 μl $549 |
Details | |
NBP2-22196R |
WB,ELISA,FC,IHC-P | PLK-1 Human,Mouse |
Mouse IgG1 3C11 |
100 μl $399 |
Details | |
NBP2-37466R |
WB,ELISA,ICC/IF | PLK-1 Human |
Mouse IgG1 1D1 |
100 μl $399 |
Details | |
Novus Biologicals, a Bio-Techne brand NBP2-50252R |
WB,ELISA | PLK-1 Human,Xenopus |
Mouse IgG2b AZ27 |
100 μl $379 |
Details | |
Novus Biologicals, a Bio-Techne brand NB100-2792R |
WB,ELISA | PLK-1 Human,Mouse,Xenopus |
Mouse IgG2a AZ24 |
0.1 ml $499 |
Details | |
Novus Biologicals, a Bio-Techne brand NBP2-73472R |
WB,IHC | PLK-1 Human |
Mouse IgG2b OTI1D4 |
0.1 ml $679 |
Details | |
Novus Biologicals, a Bio-Techne brand NB100-2747R |
WB,ELISA | PLK-1 Xenopus |
Mouse IgG1 AZ44 |
0.1 ml $499 |
Details | |
Browse PLK-1 / DyLight 550 antibodies. |